Brief: IGM Biosciences Inc Reports Quarterly Loss Per Share Of $1.19

IGM Biosciences

30/03/2023 21:20

March 30 (Reuters) - IGM Biosciences Inc  IGMS.O :
    * IGM BIOSCIENCES ANNOUNCES FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * IGM BIOSCIENCES INC - EXPECTS TO END 2023 WITH A BALANCE
OF
APPROXIMATELY $200 MILLION IN CASH AND INVESTMENTS
    * IGM BIOSCIENCES INC - EXPECTS BALANCE TO ENABLE IT TO FUND
ITS
OPERATING EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO THE
SECOND HALF OF 2024
    * IGM BIOSCIENCES INC- QTRLY LOSS PER SHARE $1.19

Source text for Eikon:  ID:nGNX6SMnSQ 
Further company coverage:  IGMS.O 

 ((Reuters.Briefs@thomsonreuters.com;;))